Apo-Divalproex 125 mg

APO-Divalproex 125 MG is a delayed-release tablet containing valproic acid (divalproex sodium). This medication is commonly used for managing certain types of seizures and mood disorders. It is manufactured by Apotex Inc. in Canada.

APO-Divalproex 125 MG is primarily used for the treatment of epilepsy and bipolar disorder. It helps to control seizures by affecting the chemicals in the brain that may cause them. Additionally, it is used to manage manic episodes associated with bipolar disorder, helping to stabilize mood. The medication is often prescribed by healthcare providers to maintain consistent levels of the active ingredient in the body.

Common effects of APO-Divalproex 125 MG may include drowsiness, dizziness, and nausea. Some users may experience weight changes or tremors. These effects can vary from person to person and may diminish over time as the body adjusts to the medication. It is important to monitor any persistent or severe side effects and consult a healthcare professional if necessary.

APO-Divalproex 125 MG should be handled with care, especially by pregnant women or those planning to become pregnant, as it may pose risks to fetal development. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring of liver function and blood levels may be recommended to ensure safety and effectiveness.

APO-Divalproex 125 MG may interact with other medications, including certain anticonvulsants, antidepressants, and anticoagulants. Alcohol consumption should be avoided as it can increase the risk of side effects. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.